All Stories

  1. Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition
  2. Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies
  3. Importancia del conocimiento de los mecanismos implicados en la revascularización postisquémica en cirugía vascular
  4. Papel de endoglina en los eventos fisiológicos involucrados en la revascularización postisquémica
  5. Sub-nephrotoxic cisplatin sensitizes rats to acute renal failure and increases urinary excretion of fumarylacetoacetase
  6. Endoglin involvement in integrin-mediated cell adhesion as a putative pathogenic mechanism in hereditary hemorrhagic telangiectasia type 1 (HHT1)
  7. A Survey of Performance Modeling and Simulation Techniques for Accelerator-Based Computing
  8. Regulation of renal fibrosis by the transforming growth factor beta-1 receptor Alk1
  9. Hemopexin, a potential biomarker for the diagnosis of chronic predisposition to acute kidney injury
  10. Multi-objective environmental model evaluation by means of multidimensional kernel density estimators: Efficient and multi-core implementations
  11. Development of an “In Situ” renal perfusion system to study the origin of urinary biomarkers in a nephrotoxicity model induced by gentamicin
  12. L-Endoglin Overexpression Increases Renal Fibrosis after Unilateral Ureteral Obstruction
  13. Hypertension and Hyperglycemia Synergize to Cause Incipient Renal Tubular Alterations Resulting in Increased NGAL Urinary Excretion in Rats
  14. Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals
  15. ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts
  16. Interferon-γ Reduces the Proliferation of Primed Human Renal Tubular Cells
  17. The role of endoglin in kidney fibrosis
  18. Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy
  19. Impaired Wound Repair in Adult Endoglin Heterozygous Mice Associated with Lower NO Bioavailability
  20. Effect of Angiotensin II and Small GTPase Ras Signaling Pathway Inhibition on Early Renal Changes in a Murine Model of Obstructive Nephropathy
  21. ALK1-Smad1/5 signaling pathway in fibrosis development: Friend or foe?
  22. Cardiotrophin-1 Administration Protects from Ischemia-Reperfusion Renal Injury and Inflammation
  23. The small GTPase N-Ras regulates extracellular matrix synthesis, proliferation and migration in fibroblasts
  24. Met signaling in cardiomyocytes is required for normal cardiac function in adult mice
  25. The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?
  26. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast
  27. Membrane and Soluble Forms of Endoglin in Preeclampsia
  28. P-235 RCMD patients have an abnormal angiogenesis related to endoglin
  29. Renal fibrosis and progression
  30. Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet
  31. Increased urinary excretion of albumin, hemopexin, transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats
  32. Cardiotrophin-1 Administration Prevents the Renal Toxicity of Iodinated Contrast Media in Rats
  33. Endoglin Haploinsufficiency Promotes Fibroblast Accumulation during Wound Healing through Akt Activation
  34. Alteration in Endoglin-Related Angiogenesis in Refractory Cytopenia with Multilineage Dysplasia
  35. Heterozygous Deficiency of Endoglin Decreases Insulin and Hepatic Triglyceride Levels during High Fat Diet
  36. Concerted Action of ANP and Dopamine D1-Receptor to Regulate Sodium Homeostasis in Nephrotic Syndrome
  37. Effects and Mechanism of Organ Protection by Cardiotrophin-1
  38. Effects and Mechanism of Organ Protection by Cardiotrophin-1
  39. Oxysterol-Induced Soluble Endoglin Release and Its Involvement in Hypertension
  40. Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration
  41. Subcellular targets of cisplatin cytotoxicity: An integrated view
  42. Functional specific roles of H-ras and N-ras. A proteomic approach using knockout cell lines
  43. Delayed mTOR Inhibition with Low Dose of Everolimus Reduces TGFβ Expression, Attenuates Proteinuria and Renal Damage in the Renal Mass Reduction Model
  44. Angiogenic Stimuli and Endoglin Absence Induces Brain Arteriovenous Malformations: Are Local Endoglin Deletion and Angiogenesis the ‘Second Hit’ That Is Necessary for Arteriovenous Malformations Formation in HHT-1?
  45. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects
  46. H-Ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts
  47. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes
  48. Increased oxidative stress, the renin–angiotensin system, and sympathetic overactivation induce hypertension in kidney androgen-regulated protein transgenic mice
  49. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
  50. Osteoprotegerin and Diabetes-Associated Pathologies
  51. Effects of deferasirox on renal function and renal epithelial cell death
  52. Necrotic Concentrations of Cisplatin Activate the Apoptotic Machinery but Inhibit Effector Caspases and Interfere with the Execution of Apoptosis
  53. Urinary levels of regenerating islet-derived protein III β and gelsolin differentiate gentamicin from cisplatin-induced acute kidney injury in rats
  54. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view
  55. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications
  56. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients
  57. Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein
  58. Common pathophysiological mechanisms of chronic kidney disease: Therapeutic perspectives
  59. An Integrative Overview on the Mechanisms Underlying the Renal Tubular Cytotoxicity of Gentamicin
  60. Targeted Genomic Disruption of H-Ras Induces Hypotension Through a NO-cGMP-PKG Pathway-Dependent Mechanism
  61. The physiological role of endoglin in the cardiovascular system
  62. Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes
  63. Chronic overexposure to uranium predisposes to acute renal failure
  64. Metformin prevents functional and histologic alterations of gentamicin-induced nephrotoxicity
  65. New diagnostic markers of acute renal failure induced by gentamicin
  66. Early energetic catastrophe does not prevent the execution of apoptosis induced by cisplatin
  67. Renoprotective effects of quercetin on cisplatin-induced nephrotoxicity. Role of TNF-alpha, NF-kappaB and iNOS
  68. Inhibition of protein geranylation underlies the antiproliferative effect of fluvastatin in MDA-MB-231 and 3LL cells
  69. Nephrotoxicity of Uranium: Pathophysiological, Diagnostic and Therapeutic Perspectives
  70. An integrative view on the role of TGF-β in the progressive tubular deletion associated with chronic kidney disease
  71. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway
  72. Differential effects of 17β-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency
  73. Evaluación de nuevos donadores de óxido nítrico en el trasplante renal experimental
  74. Lanthanum activates calcium-sensing receptor and enhances sensitivity to calcium
  75. Mechanisms Involved in the Genesis of Diabetic Nephropathy
  76. Mechanisms Involved in the Genesis of Diabetic Nephropathy
  77. Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice
  78. Analysis of K-Ras Nuclear Expression in Fibroblasts and Mesangial Cells
  79. Reply: Endoglin: A Marker of Neoplasias or Rather of Neo-Angiogenesis?
  80. Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy
  81. Evaluation of Oxidant-Antioxidant Balance in Patients on Maintenance Haemodialysis: A Comparative Study of Dialyzers Membranes
  82. Potential utility of PPARα activation in the prevention of ischemic and drug-induced acute renal damage
  83. The emerging role of TGF-β superfamily coreceptors in cancer
  84. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
  85. Protective Effect of New Nitrosothiols on the Early Inflammatory Response to Kidney Ischemia/Reperfusion and Transplantation in Rats
  86. Fibroblast activation and myofibroblast generation in obstructive nephropathy
  87. Kidney Androgen-Regulated Protein Transgenic Mice Show Hypertension and Renal Alterations Mediated by Oxidative Stress
  88. Targeted genomic disruption of H-ras and N-ras has no effect on early renal changes after unilateral ureteral ligation
  89. Endoglin as a marker in cervical paragangliomas
  90. Effect of different antihypertensive treatments on Ras, MAPK and Akt activation in hypertension and diabetes
  91. Prospective comparative analysis of the angiogenic capacity of monocytes and CD133+ cells in a murine model of hind limb ischemia
  92. Teaching integrative physiology using the quantitative circulatory physiology model and case discussion method: evaluation of the learning experience
  93. Cardiovascular Homeostasis in Hypotension Associated With Initial Stages of Severe Acute Pancreatitis
  94. The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation
  95. S-Endoglin Expression Is Induced in Senescent Endothelial Cells and Contributes to Vascular Pathology
  96. Quercetin exerts a protective effect on cadmium-induced nephrotoxicity through its ability to inhibit pro-inflammatory mediators
  97. Subtoxic doses of gentamicin sensitize rats to acute renal failure
  98. Improvement of renal blood flow underlies the beneficial effect of quercetin on cisplatin nephrotoxicity
  99. Therapeutical Relevance of MAP-Kinase Inhibitors in Renal Diseases: Current Knowledge and Future Clinical Perspectives
  100. Activation of Erk1/2 and Akt following unilateral ureteral obstruction
  101. Effect of the flavonoid quercetin on cadmium-induced hepatotoxicity
  102. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction
  103. Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perifused rat hepatocytes
  104. L- and S-endoglin differentially modulate TGF 1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts
  105. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction
  106. Involvement of small Ras GTPases and their effectors in chronic renal disease
  107. Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients
  108. Glomerular nephrotoxicity of aminoglycosides
  109. Effect of adenosine in extracellular matrix synthesis in human and rat mesangial cells
  110. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia
  111. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia
  112. Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-β signaling
  113. Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia
  114. Loss of Vav2 Proto-Oncogene Causes Tachycardia and Cardiovascular Disease in Mice
  115. The Flavonoid Silibinin Decreases Glucose-6-Phosphate Hydrolysis in Perifused Rat Hepatocytes by an Inhibitory Effect on Glucose-6-Phosphatase
  116. Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties
  117. Expression of Ras in cadmium-induced nephrotoxicity
  118. Effect of quercetin in cadmium-induced hepatotoxicity
  119. TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells
  120. The lord of the ring: Mandatory role of the kidney in drug therapy of hypertension
  121. Involvement of H- and N-Ras isoforms in transforming growth factor-β1-induced proliferation and in collagen and fibronectin synthesis
  122. Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction
  123. Resveratrol inhibits gentamicin-induced mesangial cell contraction
  124. Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats
  125. Endoglin Modulation of TGF-ß1-Induced Collagen Synthesis is Dependent on ERK1/2 MAPK Activation
  126. Ciclooxigenasas y función renal
  127. Ciclooxigenasas y función renal
  128. Estudio de farmacovigilancia para evaluar la seguridad y la efectividad del tratamiento con losartán: efectos a largo plazo de losartán solo o en combinación sobre la uricemia
  129. Relación entre el estrés oxidativo y los procesos psicológicos y sociales en personas mayores
  130. Gentamicin induces Jun-AP1 expression and JNK activation in renal glomeruli and cultured mesangial cells
  131. Temporal changes in renal endoglin and TGF-β1 expression following ureteral obstruction in rats
  132. Exogenous nitric oxide modulates the systemic inflammatory response and improves kidney function after risk-situation abdominal aortic surgery
  133. Characterization of murine S-endoglin isoform and its effects on tumor development
  134. Manejo de agua y sodio por el riñón senescente. Interpretación de una técnica de aclaramiento para su estudio funcional
  135. Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration
  136. Role of Vascular Nitric Oxide in Experimental Liver Cirrhosis
  137. Intrarenal Administration of Molsidomine, a Molecule Releasing Nitric Oxide, Reduces Renal Ischemia-Reperfusion Injury in Rats
  138. Gentamicin treatment induces simultaneous mesangial proliferation and apoptosis in rats
  139. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation
  140. Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure
  141. Expression of the TGF-β coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis
  142. Induction of DNA synthesis by ligation of the CD53 tetraspanin antigen in primary cultures of mesangial cells
  143. Verapamil Reverts Acute Renal Functional Impairment Induced by Angiotensin II Converting Enzyme Inhibitors
  144. Role of Reactive Oxygen Species in Renal Function and Diseases
  145. Protective Effect of trans -Resveratrol on Gentamicin-Induced Nephrotoxicity
  146. Involvement of reactive oxygen species on gentamicin-induced mesangial cell activation
  147. Endoglin Upregulation During Experimental Renal Interstitial Fibrosis in Mice
  148. In vivo bradykinin B2 receptor activation reduces renal fibrosis
  149. In vivo bradykinin B2 receptor activation reduces renal fibrosis
  150. In vivo bradykinin B2 receptor activation reduces renal fibrosis
  151. Cyclosporin Effect on Rat Aorta α1-Adrenoceptors and Their Transduction Mechanisms
  152. Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis
  153. Effects of nitric oxide syntase-inhibitors on early hepatic fibrosis induced by bile duct ligation
  154. Transforming growth factor-β1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L 6 E 9 myoblasts
  155. TRANSFORMING GROWTH FACTOR-β1 (TGF-β1): A POTENTIAL RECOVERY SIGNAL IN THE POST-ISCHEMIC KIDNEY
  156. Increased renal glomerular endothelin-1 release in gentamicin-induced nephrotoxicity
  157. Effect of chronic and progressive aortic constriction on renal function and structure in rats
  158. Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters
  159. Up-regulation of endoglin, a TGF- -binding protein, in rats with experimental renal fibrosis induced by renal mass reduction
  160. Endoglin Expression in Human and Rat Mesangial Cells and Its Upregulation by TGF-β1
  161. Nitric oxide and cirrhosis of the liver
  162. Effect of chronic and progressive aortic constriction on renal function and structure in rats
  163. Role of glomerular nitric oxide in glycerol-induced acute renal failure
  164. Increased Apoptosis Susceptibility in Mesangial Cells from Spontaneously Hypertensive Rats
  165. Role of glomerular nitric oxide in glycerol-induced acute renal failure
  166. Endoglin is expressed in the chicken vasculature and is involved in angiogenesis
  167. Potential role of platelet activating factor in acute renal failure
  168. Antihypertensive Effect of Trandolapril and Verapamil in Rats with Induced Hypertension
  169. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation
  170. Interaction between prostanoids and nitric oxide in the control of tubular function in rats with chronic bile duct ligation
  171. Interaction between prostanoids and nitric oxide in the control of tubular function in rats with chronic bile duct ligation
  172. Glomerular cell proliferation and apoptosis in uninephrectomized spontaneously hypertensive rats
  173. Effect of cicletanine on renal cGMP production
  174. Antihypertensive Action of Trandolapril and Verapamil in Spontaneously Hypertensive Rats After Unilateral Nephrectomy
  175. Nitrite production does not always reflect nitric oxide synthesis by isolated glomeruli
  176. Effect of Cyclosporin A on Rat Smooth-Muscle Cell Proliferation
  177. Effect of chronic N G -nitro-L-arginine methyl ester (L-NAME) on blood pressure and renal function in conscious uninephrectomized spontaneously hypertensive rats
  178. Effect of chronic NG-nitro-L-arginine methyl ester (L-NAME) on blood pressure and renal function in conscious uninephrectomized spontaneously hypertensive rats
  179. Effect of cicletanine on renal cGMP production
  180. BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis
  181. Cardiovascular effects of elgodipine and nifedipine compared in anaesthetized rats
  182. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: Role of inducible nitric oxide synthase activation
  183. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats
  184. Renal effects of antihypertensive therapy in uninephrectomized diabetic rats
  185. Effect of nitric oxide synthesis modification on renal function in gentamicin-induced nephrotoxicity
  186. Adenosine Activates Mesangial Cell Proliferation
  187. Role of Atrial Natriuretic Factor, Hemodynamic Changes and Renal Nerves in the Renal Effects of Intraperitoneal Morphine in Conscious Rats
  188. Increased severity of gentamicin nephrotoxicity in aging rats is mediated by a reduced glomerular nitric oxide production
  189. Dynamics of renal glucose reabsorption in rat
  190. The Role of Platelet-Activating Factor and the Effect of PAF Blocking Receptors on the Outcome of ARF
  191. Comparative Effects of Dopexamine and Dopamine on Glycerol-Induced Acute Renal Failure in Rats
  192. Factors Associated with Hyperdynamic or Hypodynamic Circulation and Role of Platelet-Activating Factor in Hemodynamic Alterations in Bacterial Peritonitis in Conscious Rats
  193. Effect of Hypothalamic-Hypophysary Inhibitory Factor on Mesangial Cell Activation
  194. Effect of adenosine and adenosine agonists on amylase release from rat pancreatic lobules
  195. Gentamicin activates rat mesangial cells. A role for platelet activating factor
  196. The effect of LU-49938 (nexopamil) on the activation by serotonin of mesangial cells
  197. Increased Glomerular Nitric Oxide Synthesis in Ischemic Acute Renal Failure in the Rat
  198. Effect of Felodipine on Systemic Hemodynamics of Spontaneous Mild-Hypertensive Aged Rats
  199. Effects of a new dihydropyridine derivative, S12968 (pranedipine), and its stereoisomer, S12967, on renal effects of endothelin-1
  200. Effect of Atrial Natriuretic Peptide and Calcium Antagonists on Platelet-Activating Factor-Induced Contraction and Intracellular Calcium Mobilization in Rat Mesangial Cells
  201. Nitric Oxide-dependent Cyclic GMP Synthesis by Isolated Rat Glomeruli
  202. Increased glomerular nitric oxide synthesis in gentamicin-induced renal failure
  203. Effect of extracellular volume expansion on erythrocyte cation transport in cirrhotic rats
  204. Renal Catabolism of Truncated Glucagon-Like Peptide 1
  205. Effects of the enantiomers of a new dihydropyridine derivative, S12968 and S12967, on renal functions in rats
  206. A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation
  207. Effect of Ouabain and Hypothalamic, Hypophysary Inhibitory Factor on Rat Mesangial Cell Proliferation
  208. Effect of gentamicin treatment on glutamine and lactate metabolism by the renal cortex of the rat
  209. Gentamicin nephrotoxicity in rats is not modified by verapamil
  210. Effect of adenosine and adenosine analogues on cyclic AMP accumulation in cultured mesangial cells and isolated glomeruli of the rat
  211. Renal Cortical Intermediary Metabolism in the Recovery Phase of Postischemic Acute Renal Failure in the Dog
  212. Is Renal Protection with Calcium Antagonists Possible?
  213. Effect of platelet activating factor antagonist treatment on gentamicin nephrotoxicity
  214. A role for endothelin in the maintenance of post-ischaemic renal failure in the rat.
  215. Effects of Adenosine (ADO) and A1and A2Ado Agonists on Calcium Uptake and cAMP Levels in Cultured Rat Mesangial Cells (MC)
  216. Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF
  217. Activation by Adenosine of Cultured Mesangial Cells: Receptors Involved and Intracellular Mechanisms
  218. Intermediary Metabolism in Renal Proximal Tubules in the Recovery Phase of Experimental Renal Ischemia in Dogs
  219. Renal Function Derangements Induced by Portacaval Anastomosis in Normal Rats
  220. Renal Transplantation and Red Blood Cell Sodium Transport: Role of Prednisone Treatment
  221. Effects of Physical Training during the Growth on the Granulation of Myo-Epithelioid Cells of the Rat Kidney
  222. Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels
  223. Renal catabolism of human glucagon-like peptides 1 and 2
  224. Intravascular and Interstitial Fluid Dynamics in Rats Treated with Minoxidil
  225. Hepatic haemodynamic changes after portacaval anastomosis in normal, cirrhotic and chronic prehepatic portally hypertensive rats
  226. Disturbances in Renal Function Associated with Hepatic Dysfunction
  227. Effect of extracellular volume expansion on erythrocyte sodium transport in rats
  228. Alterations in the physicochemical properties of renal cortical membranes in rats with experimental cirrhosis of the liver
  229. Effect of dietary sodium intake on the pressor reactivity to angiotensin II in rats with experimental cirrhosis of the liver
  230. Effect of endothelin on systemic and regional hemodynamics in rats
  231. Effect of valproate infusion in vivo on renal metabolism in fasted rats
  232. Prostanoid production in post-gastrectomy gastritis
  233. Adenosine induces mesangial cell contraction by an A1-type receptor
  234. Effect of endothelin on renal function in rats
  235. Effect of Valproate on Lactate and Glutamine Metabolism by Rat Renal Cortical Tubules
  236. Actions of cyclosporin A on cultured rat mesangial cells
  237. Effect of portacaval surgical anastomosis on systemic and splanchnic hemodynamics in portal hypertensive, cirrhotic rats
  238. Effect of valproate on renal metabolism in the intact dog
  239. Vascular reactivity to norepinephrine in rats with cirrhosis of the liver
  240. BN 52021 pretreatment protects against glycerol induced acute renal failure
  241. BN 52021 inhibits glomerular and mesangial cell contraction induced by cyclosporin A (CSA)
  242. Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor
  243. Atrial Natriuretic Peptide in Rats with Experimental Cirrhosis of the Liver without Ascites*
  244. Absence of an endogenous regulator of Na + ,K + -ATPase activity in the tissues of cirrhotic rats
  245. Atrial natriuretic peptide inhibits glomerular contraction induced by angiotensin II and platelet activating factor
  246. Adenosine induces a calcium-dependent glomerular contraction
  247. Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver
  248. Changes in renal function and morphology in aging laboratory animals
  249. Glomerular filtration and renal blood flow in the aged
  250. Contributors
  251. Effect of Head-Out Water Immersion on Atrial Natriuretic Peptide Plasma Levels in Cirrhotics with Ascites
  252. Atrial Natriuretic Peptide Modulates Isolated Rat Glomeruli Contraction
  253. Effects of the platelet-activating factor antagonist BN 52021 on the hemodynamics of rats with experimental cirrhosis of the liver
  254. Lack of a direct regulatory effect of atrial natriuretic factor on prostaglandins and renin release by isolated rat glomeruli
  255. Hemodynamic Effects of Vanadate Administration in Rats with Different Levels of Sodium Intake
  256. Effect of volume expansion on hemodynamics, capillary permeability and renal function in conscious, cirrhotic rats
  257. Effect of captopril infusion on systemic and renal haemodynamics in conscious hypertensive rats with chronic, progressive aortic ligation
  258. PLASMA LEVELS OF ATRIAL NATRIURETIC PEPTIDE IN CIRRHOTIC PATIENTS
  259. Effects of BN 52021 on hemodynamics on rats with experimental cirrhosis of the liver
  260. Lack of effect of synthetic atrial natriuretic factor on rubidium uptake by human erythrocytes
  261. Progressive renovascular hypertension by increasing aortic constriction in rats
  262. Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individuals
  263. Mechanisms of the Impaired Diuretic and Natriuretic Responses to a Sustained and Moderate Saline Infusion in Rats with Experimental Cirrhosis
  264. Renal Actions of Orthovanadate in the Dog
  265. Renal Metabolism of Gut Glucagon-Like Immunoreactivity*
  266. Functional Compensatory Changes after Unilateral Nephrectomy in Rats
  267. Pathogenesis of Hyperprolactinemia in Uremic Rats
  268. Intrasplenic infusion. A simple method for intraportal infusion in rats
  269. GENERAL AND INTRARENAL HEMODYNAMIC ALTERATIONS AFTER UNILATERAL NEPHRECTOMY IN RATS
  270. Sodium excretion after bilateral adrenalectomy in rats with experimental cirrhosis
  271. An escape phenomenon from water and sodium retention induced by propranolol in rats
  272. Physiology of the Healthy Aging Kidney
  273. The Mechanisms of Age-Associated Glomerular Sclerosis
  274. Acute Renal Failure in the Aged
  275. Biology of the Aging Process and Its Clinical Consequences